A recent study reveals that individuals who come off new GLP-1 drugs like Wegovy and Mounjaro tend to recover shed pounds far faster than those who halt conventional diet and exercise plans.
Research printed in a prominent health publication demonstrates that while obese people frequently drop about a fifth of their total mass while on the medication, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Individuals using these drugs need to be informed of the potential of quick rebound weight gain when the treatment concludes," warns expert Dr. Susan Jebb.
This pace of recovery suggests a return to starting mass within about one and a half years.
Analyzing Therapies
The research, which reviewed 37 of trials involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with other pills.
The team emphasize that individuals who lose weight through diet and exercise typically experience a less rapid weight regain—around 100 grams monthly—post-intervention.
Explaining the Quick Regain
Doctors propose the mechanism of the injections is key to understanding the accelerated regain.
The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 levels far above than normal could lead to the system to produce less of its own natural hormone, and could reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making excessive eating far more likely."
An Ongoing Disease?
Health authorities recommend the jabs for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
Many experts say that, due to the likelihood of relapse, the treatment should be considered life-long.
This perspective is supported by drug manufacturers, who note that the findings "emphasize the persistent nature of obesity," comparing it to managing diseases like diabetes.
User Testimonies
Individuals who have come off the jabs explain a powerful resurgence of cravings.
"It was like a trigger that goes on and you're instantly starving," described an individual.
The struggle is worsened if patients have not adopted permanent lifestyle or habit modifications during treatment.
Growing Adoption
Figures show that millions of people in the UK have tried weight-loss jabs in the last 12 months, with interest continuing to grow.
- Adoption is higher among females compared to males.
- The middle-aged age group shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
Finally, experts stress that while these medications are potent tools for shedding pounds, they are not a permanent cure and lasting health benefits relies on integrated lifestyle support.
